OBJECTIVE: The possibility of brain volume reserve effects was examined in a sample of geriatric outpatients with mild cognitive impairment (MCI), Alzheimer's disease (AD) and vascular dementia (VaD). The total intracranial volume (ICV) served as an estimate of the maximum attained brain volume in life. METHODS: Subjects (n = 181, mean age 60.7) were consecutive referrals to a geriatric outpatients clinic (n = 96) and a group of age-matched healthy control subjects (n = 85). ICV and brain volume were attained from T1-weighted magnetic resonance images using a stereological method. Hippocampal atrophy was assessed with a visual rating scale. RESULTS: ICV was significantly smaller in patients with AD and VaD than in control subjects, but effect size was small. After adjusting for age and gender, having ICV in the smallest quartile significantly increased the risk of cognitive impairment (either MCI or dementia). In patients with dementia, but not in MCI, severity of cognitive impairment and ICV were moderately correlated. The effect of ICV on cognition was not mediated by hippocampal atrophy. CONCLUSIONS: These findings are compatible with volume reserve effects that modify the clinical expression of symptoms in both AD and VaD. They may have implications for the design of neuroimaging studies that use ICV for normalization procedures.
OBJECTIVE: The possibility of brain volume reserve effects was examined in a sample of geriatric outpatients with mild cognitive impairment (MCI), Alzheimer's disease (AD) and vascular dementia (VaD). The total intracranial volume (ICV) served as an estimate of the maximum attained brain volume in life. METHODS: Subjects (n = 181, mean age 60.7) were consecutive referrals to a geriatric outpatients clinic (n = 96) and a group of age-matched healthy control subjects (n = 85). ICV and brain volume were attained from T1-weighted magnetic resonance images using a stereological method. Hippocampal atrophy was assessed with a visual rating scale. RESULTS:ICV was significantly smaller in patients with AD and VaD than in control subjects, but effect size was small. After adjusting for age and gender, having ICV in the smallest quartile significantly increased the risk of cognitive impairment (either MCI or dementia). In patients with dementia, but not in MCI, severity of cognitive impairment and ICV were moderately correlated. The effect of ICV on cognition was not mediated by hippocampal atrophy. CONCLUSIONS: These findings are compatible with volume reserve effects that modify the clinical expression of symptoms in both AD and VaD. They may have implications for the design of neuroimaging studies that use ICV for normalization procedures.
Authors: R Perneczky; S Wagenpfeil; K L Lunetta; L A Cupples; R C Green; C Decarli; L A Farrer; A Kurz Journal: Neurology Date: 2010-07-13 Impact factor: 9.910
Authors: Markus D Schirmer; Mark R Etherton Md PhD; Adrian V Dalca PhD; Anne-Katrin Giese Md; Lisa Cloonan MSc; Ona Wu PhD; Polina Golland PhD; Natalia S Rost Md Mph Faan Journal: J Stroke Cerebrovasc Dis Date: 2018-09-28 Impact factor: 2.136
Authors: Jagan A Pillai; Linda K McEvoy; Donald J Hagler; Dominic Holland; Anders M Dale; David P Salmon; Douglas Galasko; Christine Fennema-Notestine Journal: J Clin Exp Neuropsychol Date: 2012-08-21 Impact factor: 2.475
Authors: Yuan Xu; Daniel J Valentino; Ann I Scher; Ivo Dinov; Lon R White; Paul M Thompson; Lenore J Launer; Arthur W Toga Journal: Neuroimage Date: 2007-12-27 Impact factor: 6.556
Authors: Selam Negash; Sharon Xie; Christos Davatzikos; Christopher M Clark; John Q Trojanowski; Leslie M Shaw; David A Wolk; Steven E Arnold Journal: Alzheimers Dement Date: 2012-11-02 Impact factor: 21.566